Scientific Symposium “Registries for RND”

Interested in Registries for Rare Neurological Diseases? Then join our Scientific Symposium on October 10 – online and free of charge! To register click here.

PROGRAMME

Session 1: Framework for RND Registries

TIME (CET)TOPICSPEAKER
08:00Welcome and overview of
ERN-RND activities
Holm Graessner / Ludger Schöls / symposium chairs
08:05—– KEYNOTE —-
Why Registries Matter for Rare Neurological Diseases: from Natural History to Trial Readiness
Thomas Klockgether, German Centre for Neurodegenerative Diseases (DZNE), University Bonn, Germany
08:35Framework for Multistakeholder Patient Registries in the Field of Rare Neurological DiseasesNicole Wolf,
Amsterdam UMC – Amsterdam University Medical Center, Netherlands
08:55Patient Perspective: What should registries deliver for patients and families?Mary Kearney,
FARA Ireland
10:05Flash talks (5 min max): ERN-RND local registry initiatives 
09:20Coffee Break 

Session 2: Registry Examples in ERN-RND

TIME (CET)TOPICSPEAKER
09:50ERN-RND Use CaseChristina Vossler-Wolf, University Hospital Tübingen, Germany
10:05TreatHSP Natural History and
Outcome Validation Platform
Rebecca Schüle,
University Hospital Heidelberg, Germany
10:25The French MSA registryDavid Bendetowicz,
CHU – Reference Center for Rare Multiple System Atrophy, University Hospital Bordeaux, France
10:45NKX2-1 registry: Building an International Disease Registry in a Very Rare DisorderDario Ortigoza,
Sant Joan de Déu Hospital, Barcelona, Spain
11:05Panel Discussion 
11:30Coffee Break

Session 3: Regulatory and Methodological Perspectives

TIME (CET)TOPICSPEAKER
12:00Registry Qualification and Regulatory Expectations for Rare Disease Evidence GenerationKelly Plueschke,
European Medicines Agency
12:30Natural History Studies as
Historical Control Data in Trials
Ralf Reilmann,
George-Huntington-Institute, Technology-Park Münster, Germany
13:50Closing Remarks and Next Steps Panel
End of Event

For further information please contact Sophie Ripp ()

Download the programme here.